October 29, 2014
Hopewell Staff Visits New York
Some members of the Hopewell staff attended New York's Chautauqua Institution to hear Dr. Weinberger speak about his research on the role of abnormal brain development as a risk factor for Schizophrenia.
Dr. Weinberger's lab has recently identified the first specific genetic mechanism of risk for schizophrenia, and the first genetic effects that account for variation in specific human cognitive functions and in human temperament.This research is especially interesting for our clinical staff. Hopewell outcome studies have discovered that the Therapeutic Farm Community model of treatment is effective in reducing the severity of symptoms associated with Schizophrenia.
After listening to his cutting edge presentation, some of the staff was able to join extraordinary ambassadors, advocates and philanthropists Jim and Kathy Pender for a delicious lunch and touching conversation.
Back to Blog